Gilead Sciences Inc
Change company Symbol lookup
Select an option...
GILD Gilead Sciences Inc
CWBR CohBar Inc
TSLA Tesla Inc
WEC WEC Energy Group Inc
PFE Pfizer Inc
T AT&T Inc
BFC Bank First Corp
RIGMF Ridgestone Mining Inc
BAC Bank of America Corp
WFC Wells Fargo & Co
Go

Health Care : Biotechnology | Large Cap Value
Company profile

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada, Emtriva, Tybost and Vitekta. Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera. It offers Zydelig to patients with hematology/oncology diseases. Its products for patients with various cardiovascular diseases include Letairis, Ranexa and Lexiscan. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. It had operations in more than 30 countries, as of December 31, 2016.

Closing Price
$76.35
Day's Change
0.29 (0.38%)
Bid
--
Ask
--
B/A Size
--
Day's High
77.09
Day's Low
75.65
Volume
(Light)
Volume:
6,380,965

10-day average volume:
8,980,811
6,380,965

Dow ends 282 points lower, but Nasdaq logs 3rd straight record and first finish at 10,000 as Fed signals zero rates through 2022

4:09 pm ET June 10, 2020 (MarketWatch)
Print

U.S. stock benchmarks closed mostly lower Wednesday, but large-capitalization companies saw powerful gains, after the Federal Reserve projected no interest-rate increases through 2022 and pledged to use its full array of tools to help the economy and financial markets contend with the COVID-19 pandemic. The Dow Jones Industrial Average finished off 282 points, or 1%, at around 26,990, while the S&P 500 index closed down 0.5% lower at about 3,190. Meanwhile, the Nasdaq Composite Index closed up 0.7% at around 10,020, while an index of the largest 100 companies in the Nasdaq, the Nasdaq-100 , ended up 1.3% at 10,094. The finish for the Nasdaq Composite was its first above 10,000 in history. Both Nasdaq gauges closed at record heights. Those technology-laden benchmarks have been propelled higher by gains in Tesla Inc. (TSLA), Microsoft Corp. (MSFT), Apple Inc. (AAPL), as well as chipmaker Nvidia Corp. (NVDA), which helped to boost exchange-traded funds, the iShares PHLX Semiconductor ETF (SOXX) and the VanEck Vectors Semiconductor ETF. Meanwhile, shares of Hertz Global Holdings Inc. (HTZ), closed down nearly 40%, after the bankrupt car-rental company revealed that it received a delisting notice from the New York Stock Exchange. The company's shares have been one of the beneficiaries of optimism surrounding reopenings from COVID-19 lockdowns, but its surge higher also has underscored the exuberance in equities despite an economy that is in the throes of a deep recession.

-Mark DeCambre; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

June 10, 2020 16:09 ET (20:09 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.